From: Technology-enabled activation of skin cancer screening for hematopoietic cell transplantation survivors and their primary care providers (TEACH)
Proportions
SD
Group Difference
10%
5
3.3
10
6.7
15
20%
2.4
4.7
7.1
30%
1.9
3.8
5.7